TWST
Twist Bioscience Corp
NASDAQ: TWST · HEALTHCARE · DIAGNOSTICS & RESEARCH
$56.70
-4.14% today
Updated 2026-04-29
Market cap
$3.48B
P/E ratio
—
P/S ratio
8.88x
EPS (TTM)
$-1.27
Dividend yield
—
52W range
$23 – $66
Volume
1.2M
Twist Bioscience Corp (TWST) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-38.59M | $-51.30M | $-66.16M | $-87.94M | $-142.25M | $-112.24M | $-124.39M | $-142.47M | $-64.09M | $-47.63M |
| Capital expenditures | $6.23M | $6.59M | $3.69M | $14.76M | $9.87M | $27.06M | $101.86M | $27.78M | $5.08M | $28.00M |
| Depreciation | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | $857000.00 | $1.89M | $2.96M | $11.17M | $17.10M | $37.00M | $79.66M | $30.28M | $50.92M | $64.46M |
| Free cash flow | $-44.82M | $-57.90M | $-69.85M | $-102.69M | $-152.12M | $-139.31M | $-226.24M | $-170.25M | $-69.17M | $-75.63M |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | $-34.17M | $46.83M | $373.09M | $-86.78M | — | — | — |